Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia

In adults with non-promyelocytic acute myeloid leukemia (AML), high-dose cytarabine consolidation therapy has been shown to influence survival in selected patients, although the appropriate doses and schemes have not been defined. We evaluated survival after calculating the actual dose of cytarabine...

Descripción completa

Detalles Bibliográficos
Autores principales: Azevedo, M.C., Velloso, E.D.R.P., Buccheri, V., Chamone, D.A.F., Dorlhiac-Llacer, P.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2014
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321225/
https://www.ncbi.nlm.nih.gov/pubmed/25517921
http://dx.doi.org/10.1590/1414-431X20144059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321225/
https://www.ncbi.nlm.nih.gov/pubmed/25517921
http://dx.doi.org/10.1590/1414-431X20144059

Ejemplares similares